Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety Extension of Epinephrine Inhalation in Asthma
NCT01476904Phase 3Completed
- Start
- Nov 2011
- Primary completion
- Apr 2012
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of epinephrine in asthma. Started Nov 2011; status: completed.
02
Drugs
epinephrine
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01476904.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01476904.